This is the authors' abstract. We don't add key points for this paper.
) of 13.0 nM (determined by water-soluble tetrazolium salt-8 assay) and 32.0 nM (determined by cytopathic effect observation), yielding a Selectivity Index (SI) of 6376.9 and 2590.6, respectively. Mechanistic investigations, including RT-qPCR and western blotting, revealed that WRX606 does not interfere with viral adsorption or intracellular genome replication. Rather, it likely exerts its antiviral effect by interfering with the intracellular translation or stability of viral structural proteins such as hemagglutinin and neuraminidase, leading to a significant reduction in the release of progeny virions. Time-of-addition assays further confirmed that WRX606 affects broad stages of the viral life cycle leading up to release. By targeting mTORC1, WRX606 offers a potential host-directed strategy for addressing viral infections.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Yamada et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: